Navigation Links
NuRx Pharmaceuticals Retains Russo Partners for Investor Relations, Corporate Communications Counsel
Date:2/29/2008

IRVINE, Calif., Feb. 29 /PRNewswire-FirstCall/ -- NuRx Pharmaceuticals Inc. (OTC Bulletin Board: NURX) today announced it has retained Russo Partners LLC for the provision of investor relations and corporate communications counsel.

The healthcare communications firm will implement a comprehensive program that consists of investor targeting, the scheduling of presentations at industry conferences, media relations and other corporate visibility initiatives. Russo Partners will collaborate with OTC Communications, a division of Rx Communications Group LLC, on the implementation of some program tactics.

"We are in a unique position with a clinical-stage pipeline and large portfolio of retinoid and rexinoid compounds that were developed over a number of years by world-class researchers who have joined the NuRx scientific team," said Harin Padma-Nathan, M.D., NuRx's president and CEO. "We intend to initiate three to four clinical trials this year. Therefore, the need to support the associated news flow prompted us to select Russo Partners to develop and lead our communications efforts with Wall Street and the biotech/pharmaceuticals community. The firm has the healthcare industry expertise, senior-level talent and investor and media relationships that were critical to our selection of a communications partner."

Russo Partners LLC, formerly Noonan Russo, provides strategic communications services to emerging healthcare - biotech, medical device, diagnostics and healthcare services - companies worldwide. Headquartered in New York City, the firm has a West Coast office in San Diego and an affiliated office in London. For more information, visit http://www.russopartnersllc.com.

NuRx Pharmaceuticals Inc. is an emerging biotech company focused on the development of retinoid and rexinoid compounds with application in oncology (treatment, prevention and adjunctive supportive therapy), t
'/>"/>

SOURCE NuRx Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. MiddleBrook Pharmaceuticals to Announce Fourth Quarter and Full Year 2007 Financial Results on March 4, 2008
2. Wyeth Pharmaceuticals Ends Collaboration Agreements with Solvay Pharmaceuticals for Bifeprunox and Other Compounds
3. BioCryst Pharmaceuticals to Announce Fourth Quarter and Fiscal Year 2007 Financial Results on March 4, 2008
4. Anadys Pharmaceuticals Commences Phase I Clinical Trial of ANA773 in Cancer Patients
5. Memory Pharmaceuticals to Announce Fourth Quarter and Full Year 2007 Results on Thursday, March 6, 2008
6. Anadys Pharmaceuticals to Present at the Susquehanna SIGnificant Options in Healthcare Conference
7. Michael J. Simms Joins Alexza Pharmaceuticals as Senior Vice President, Operations and Manufacturing
8. Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results
9. Investor Alert from Cauley Bowman Carney & Williams, PLLC: Update on Proposed Acquisition of CollaGenex Pharmaceuticals, Inc. - CGPI
10. JSJ Pharmaceuticals Announces Launch of Aesthetic Division - Vitivia(TM)
11. Onyx Pharmaceuticals Names N. Anthony Coles, M.D. as President, Chief Executive Officer and Member of its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2014)... 2014 Deep Research Report on Global and ... study on the current state of the Nano Silver ... a basic overview of the industry, including definitions, applications ... domestic market analysis are provided with a focus on ... A comparison between the international and Chinese situation is ...
(Date:7/11/2014)... WEST PALM BEACH, Fla. , July 11, 2014 ... wide variety of high-quality peptides that are used solely ... online. To honor two successful years in business, Maxim ... Performance LLC, has just launched a new and updated ... addition, the research blog section has been updated with ...
(Date:7/11/2014)... DUBLIN , July 11, 2014 ... "International Transfection Technology Market - Global Industry Analysis, ... report to their offering. ... to introduce nucleic acids (either DNA or RNA) into ... therapy, mutation of cancer cells and protein metabolism by ...
(Date:7/11/2014)... 2014 EPFL and the University of  ... of John P. Donoghue . The American neuroscientist ... . The new Wyss Center for ... Geneva , has named as its director ... P. Donoghue , founder of Brown University,s Institute for ...
Breaking Biology Technology:2014 Nano Silver Industry in Global and China Regions Development Proposals Analysis Available at DeepResearchReports.com 22014 Nano Silver Industry in Global and China Regions Development Proposals Analysis Available at DeepResearchReports.com 3Maxim Peptide Celebrates Second Anniversary Online with an Updated Website and Special Deals Section 2International Transfection Technology Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2019 2John P. Donoghue is Taking the Lead at the Wyss Center and is Appointed Professor at EPFL and University of Geneva 2John P. Donoghue is Taking the Lead at the Wyss Center and is Appointed Professor at EPFL and University of Geneva 3
... 32 social scientists and researchers from around the world, ... have concluded that fundamental reforms of global environmental governance ... system. The scientists argued in the March 16 edition ... is now for a "constitutional moment" in world politics. ...
... 2012   Lexicon Pharmaceuticals, Inc. (Nasdaq: ... and Drug Administration (FDA) has granted its request for ... for the treatment of carcinoid syndrome.  Carcinoid syndrome is ... originate from the gastrointestinal tract and is characterized by ...
... 2012 AlphaVax, Inc. ("AVX") is pleased to report that it ... Industry Excellence Award as the Best Early-Stage Vaccine Biotech Company. The ... Washington, DC in April. AVX is pleased to ... the panel of judges as well as being recognized as a ...
Cached Biology Technology:Fundamental steps needed now in global redesign of Earth system governance 2Fundamental steps needed now in global redesign of Earth system governance 3FDA Grants Lexicon Orphan Drug Designation for Telotristat Etiprate for the Treatment of Carcinoid Syndrome 2FDA Grants Lexicon Orphan Drug Designation for Telotristat Etiprate for the Treatment of Carcinoid Syndrome 3FDA Grants Lexicon Orphan Drug Designation for Telotristat Etiprate for the Treatment of Carcinoid Syndrome 4
(Date:7/11/2014)... of mesenchymal stem cells can stimulate neurogenesis in the ... disease (AD) and improve tissue and function injury under ... on the therapeutic effect of adipose-derived stem cells (ADSCs) ... on oxidative injury and neurogenesis in the brain of ... of Life Sciences, Tsinghua University, China transplanted ADSCs into ...
(Date:7/11/2014)... that cannabinoid receptor type 1 can inhibit ... and reduce neurotransmitter release. However, some scholars ... increase extracellular Ca2+ influx and increase neurotransmitter ... Tongji Hospital Affiliated to Tongji Medical College, ... used whole cell voltage-clamp and calcium imaging ...
(Date:7/11/2014)... of all vertebrates, information is transmitted through synapses, ... signal to be passed from one brain cell ... abundant type of synapse, can be either excitatory ... memory, perception and cognition, and the balance between ... For instance, every time we learn something, ...
Breaking Biology News(10 mins):Blame it on the astrocytes 2
... a study in her lab showed that mate (mah ... the activity of an enzyme that promotes HDL (good) ... scientist Elvira de Mejia headed for Argentina where mate ... She returned with a five-year agreement signed by ...
... rare Amur leopard (Panthera pardus orientalis), one of only ... captured and health-checked by experts from a consortium of ... group of organizations, including the Russian Academy of Sciences ... (WCS) and the Zoological Society of London (ZSL) captured ...
... more than 50 Earth Observation satellites is increasing ... synoptic views of our planet. Because these satellites ... analysis and environmental monitoring can be difficult, making ... Calibration and Validation processes. More than 50 ...
Cached Biology News:More on mate tea: lower cholesterol and an international agreement 2Critically endangered Amur leopard captured 2A roadmap for calibration and validation 2
... The Rice Oligo Microarray, 22K ... of rice genes associated with biological ... abiotic stress response. Each microarray contains ... of the rice (japonica) genome focuses ...
... ELF 97 Cytological Labeling Kit provides a ... detection of cellular targets, including cell-surface receptors ... Labeling Kit contains the patented ELF 97 ... yellow-green precipitate at the site of enzymatic ...
... Ligands\n\nReceptor-related research has long been enabled by ... selected to keep pace with new discoveries. ... and services for receptor research and drug ... you do not find exactly what you ...
... Feature Extraction Software reads ... files to prepare microarray data ... , * one 2-year ... for NFP/Academic accounts , * ...
Biology Products: